Digitizing and Automating the Diagnostic Psychiatric Assessment Process
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-17
SponsorIrene Lopez Armenteros
About this trial
This is an observational study that will be responsible for the Spanish translation and cross-cultural adaptation, and validation of the Electronic Semi-Structured Psychiatric Interview for Children and Adolescents (EPSI-C), to examine, classify, prioritize, and diagnose patients.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Minors under state care without stable attachment figures to report clinical history.
Presence of global developmental disorder or moderate to severe intellectual disability.
Incomplete, inaccurate, or unclear medical data.
Trial population
Children aged between 6 and 17 years who present a clinical demand for mental health and are referred from primary care to the community mental health center Málaga Centro.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Child and adolescent psychiatric assessment
EPSI-C (Electronic Semi-Structured Psychiatric Interview for Children and Adolescents). A semi-structured diagnostic interview that assesses current episodes of psychopathology in children and adolescents aged 6 to 17 years according to the DSM-5 diagnostic criteria. The mental disorders assessed by the EPSI-C are: specific phobia, separation anxiety disorder, social anxiety disorder, panic disorder, agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder (PTSD) and complex PTSD (according to ICD-11 criteria), major and persistent depression, manic/hypomanic episode, anorexia nervosa, bulimia nervosa, binge eating disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, Tourette's disorder/tics, oppositional defiant disorder, and conduct disorder. It also includes screening for psychotic disorders and self-harm.
Time frame
At baselineSecondary outcomes
1
Content validity
Questionnaire for the Evaluation of the Content Validity of the EPSI-C. The questionnaire evaluates qualitative assessment (comprehension and wording clarity) and quantitative assessment ( Coherence, clarity, sufficiency, and relevance).
Time frame
At baseline2
Patient acceptability
Ad-hoc patient questionnaire with open-ended items assessing clarity, relevance, comfort, length, and overall satisfaction Patient-rated satisfaction and acceptability of the culturally adapted EPSI-C after completing the pilot administration.
Time frame
At baseline3
Feasibility of the EPSI-C
Feasibility of EPSI-C measured by mean score on an ad-hoc clinician evaluation form (Likert 1-4). Clinician-rated acceptability, feasibility, and perceived clinical relevance, clarity, and time length after EPSI-C administration in clinical/pilot settings.
Time frame
At baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Irene Lopez Armenteros
Lead sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Sponsor institution
Source ClinicalTrials.gov